AbbVie
The Medical Director- Early Development Oncology supports the Product Safety Lead in ensuring patient safety through surveillance, signal detection, and assessment. This role involves interpreting pharmacovigilance regulations, analyzing aggregate safety data, and contributing to the authorship of key regulatory documents. The position requires a collaborative team environment where the incumbent effectively communicates safety analyses to cross-functional teams.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
Director, Drug Safety Physician
Spyre Therapeutics
Associate Director, PV Medical Surveillance
Taiho Oncology, Inc.
Director, Safety Scientist, Pharmacovigilance
MapLight Therapeutics
Senior Safety Scientist I
Revolution Medicines
Director, Safety Physician
Summit Therapeutics,
Pharmacovigilance Scientist 2 (Safety Aggregate Report Specialist 2)
IQVIA